- Round ID
- FR-00223
- Stage
- Series D
- Round name
- Series D
- Amount
- $225M equity (plus up to $300M SoftBank commitment; up to $525M total)
Dated funding evidence
Exscientia
Series D · $225M equity (plus up to $300M SoftBank commitment; up to $525M total) · 2021-04-01
Reported round$225M equity (plus up to $300M SoftBank commitment; up to $525M total)Series D
- Disclosure date
- 2021-04-01
- Reported currency
- USD
- Companies House
- 13483814
- Evidence sources
- 2
Company
ExscientiaCH 134838142021-04-01Series D$225M equity (plus up to $300M SoftBank commitment; up to $525M total)
Resolved investor records
SoftBank Vision Fund 2Lead investorNovo HoldingsInvestorBlackRockInvestorMubadala Investment CompanyInvestorFarallon CapitalInvestorCasdin CapitalInvestorGT Healthcare CapitalInvestorMarshall WaceInvestorPivotal bioVenture PartnersInvestorBristol Myers SquibbInvestor
Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- SoftBank Vision Fund 2
- Other investors
- Novo Holdings, BlackRock, Mubadala Investment Company, Farallon Capital, Casdin Capital, GT Healthcare Capital, Marshall Wace, Pivotal bioVenture Partners, Bristol Myers Squibb
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-25
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.